Top 3 Biotech Stocks to Buy for August 2024
Explore promising biotech stocks like Vertex, Pfizer, and Merck, ready to innovate and grow in the evolving healthcare landscape.
- Latest
- Trending
Explore promising biotech stocks like Vertex, Pfizer, and Merck, ready to innovate and grow in the evolving healthcare landscape.
Explore top biotech stocks poised for growth amid market challenges. Learn about innovations and opportunities in gene therapy.
Aditxt (ADTX) stock is soaring after a major update on a clinical trial for early ovarian cancer detection, driving heavy ...
Rhythm Pharmaceuticals sees robust Q2 2024 results with $29.1M revenues due to IMCIVREE's success in treating Bardet-Biedl syndrome.
Discover how PAHO and IDB are helping countries integrate AI into public health with their new readiness assessment toolkit.
AbCellera Biologics Inc. progresses with their TCE platform and strategic partnerships, aiming for CTA submissions in Q2 2025.
Interlynk to provide SBOM generation, vulnerability reporting, and risk assessment for BIOTRONIK's life-saving products.
Amgen's Q2 profit drops due to higher expenses, but revenue sees a 20% increase, driven by Horizon acquisition.
"Semler Scientific Q2 2024: Strong operations despite 22% revenue dip, spotlight on Bitcoin investment as inflation hedge and strategic growth ...
Castle Biosciences reports 74% Q2 revenue surge to $87M, driven by test usage and price hikes, with net income rebounding ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.